Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Omniome logo — We are excited to announce we are now part of the PacBio tea...

Omniome

We are excited to announce we are now part of the PacBio team. Make sure to follow PacBio on LinkedIn for updates.

Founded 2013 United States San Diego, United States 3 employees Acquired Total: $920.00M Biopharma, Biotechnology +1

General Information

Company Name Omniome
Founded Year 2013
Location United States San Diego, United States
Employees 3
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Acquired
Social

BounceWatch is an independent company data service, not affiliated with Omniome. To contact Omniome, visit omniome.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Omniome compare?

A PDF of Omniome and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Omniome soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Omniome

Omniome, a San Diego-based biotechnology company founded in 2013, has set its sights on becoming a leader in clinical sequencing. The company boasts a proprietary DNA sequencing platform that prides itself on delivering unparalleled accuracy. With a solid backing from prominent life sciences venture investors and a seasoned management team, Omniome has secured an impressive $60.00M Series C investment in January 2020 from noteworthy investors including Arch Venture Partners, Biomatics Capital Partners, Domain Associates, Decheng Capital, Nan Fung Life Sciences, Tigris Ventures, Madrone Capital Partners, and Altitude Life Science Ventures. This underscores the confidence these stakeholders have in Omniome's vision and technology. The company's commitment to fostering a quality-driven, startup environment promises ongoing success. The recent acquisition by the PacBio team further solidifies Omniome's position as a player to watch in the biotechnology and life sciences industries.

Business keywords: DNA sequencing, PacBio, San Diego, start-up, venture investors, clinical sequencing, life sciences, accuracy, quality-focused, innovation, management team, proprietary platform, talented team

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition $800.00M 1
Pacific Biosciences
01 Jul 2021
Series C $60.00M 7
Arch Venture Partners Biomatics Capital Partners Domain Associates
Arch Venture Partners, Biomatics Capital Partners +5
01 Jan 2020
Series B $60.00M 7
Arch Venture Partners Biomatics Capital Partners Domain Associates
Arch Venture Partners, Biomatics Capital Partners +5
01 Jul 2018
Series A Undisclosed -
01 Jan 2016
Seed Undisclosed -
01 May 2014

Omniome Alternatives & Competitors

View All Alternatives
Omniome vs
IconOVir Bio
IconOVir Bio United States

Pushing the envelope: Our mission is to cure cancer and restore life to every patient everywhere

Series A
7 employees
Biotechnology, Life Sciences
Omniome vs
Norgen Biotek
Norgen Biotek Canada

Facilitating Excellence in Research

84 employees
Biotechnology, Life Sciences
Omniome vs
Qinecsa - formerly MyMeds&Me
Qinecsa - formerly MyMeds&Me United Kingdom

MyMeds&Me, a Qinecsa Solutions company, provide end-to-end pharmacovigilance solutions to simplify a...

Venture round
16 employees
Biopharma, Biotechnology
View all alternatives

FAQ About Omniome

We are excited to announce we are now part of the PacBio team. Make sure to follow PacBio on LinkedIn for updates.
Omniome was founded in 2013.
Omniome is headquartered in San Diego, United States.
Omniome operates in Biopharma, Biotechnology and Life Sciences. Its work centres on DNA sequencing, PacBio, San Diego and start-up.
Omniome has approximately 3 employees.
Omniome has completed 5 funding rounds, raising a total of $920.00M. The latest funding stage is Acquired.
Top alternatives and competitors to Omniome include IconOVir Bio, Norgen Biotek, Qinecsa - formerly MyMeds&Me. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Omniome and IconOVir Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Omniome, https://bouncewatch.com/company/omniome, updated 11 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes